Faculty and Research Careers in the NIH Intramural Research Program
|
Join Dr. Charles R. Dearolf and Dr. Roland A. Owens of the NIH Office of Intramural Research for a Zoom Webinar on Faculty-level Research Careers in the NIH Intramural Research Program on Thursday, September 14, 2023. It will include information about the Stadtman and NIH Lasker Clinical Research Scholars searches, as well as the Distinguished Scholars Program. Register Now»
|
2023 Cancer Control Program Annual Retreat
|
Cancer Control Program Leaders Samir Gupta, M.D., MSCS, AGAF and Noe Crespo, Ph.D., M.P.H. cordially invite you to the 2023 Cancer Control Annual Retreat, which will be held Wednesday, September 13, 2023. This year's retreat will feature keynote speaker Dr. Katrina Goddard and expert discussion on health equity, cancer screening, environmental, occupational, and climate change, cancer survivorship, and cancer control. Visit Website»
|
Moores Research Program Seminar Series Return
|
Welcome back! Hopefully you enjoyed a relaxing summer. With the academic year beginning in just 2 weeks, Moores Research Administration would like to remind you that the various Moores research program seminar series will resume soon. View Announcement and Schedule»
|
|
|
September 13, 2023 | 11:30 a.m. PT
Goldberg Auditorium
|
September 18, 2023 | 12:00 p.m. to 1:00 p.m.
BSB Barren Auditorium
|
September 20, 2023 | 12:00 p.m. to 1:00 p.m.
Comer Commons
|
October 12 & 13, 2023
UC San Diego
|
|
|
Oncology Live CME Series: Integrated Multidisciplinary Treatment for Patients with Advanced Prostate Cancer
|
This series features engaging, live presentations via a virtual platform. The focus is the multidisciplinary management of advanced prostate cancer covering diagnostics, surgical treatment, radiation therapy, and systemic treatment strategies. The series features multidisciplinary lectures in urology, radiation oncology, and medical oncology, with a practical panel discussion in clinical management options for patients. Moores Members Dr. Rana R. McKay, Dr. Aditya Bagrodia, and Dr. Brent Rose will deliver presentations.
|
Early Career Cancer Research Information Session with Dr. Katrina Goddard
|
Early career trainees, such as junior faculty, post-doctoral fellows, pre-doctoral candidates, and students, are invited to join a small audience as Dr. Goddard (Director, NCI Division of Cancer Control and Population Sciences) talks with pre-selected Moores early-career cancer researchers about NCI opportunities to support their research and/or interests on Wednesday, September 13, 2023. This is a unique experience for trainees to listen to the conversation and gain insight of the opportunities, interests, foci, and future directions of the NCI.
Seats are limited, and RSVP is required for catering purposes—light breakfast will be provided. After clicking the RSVP button below, please use the "Respond" button on the following page to RSVP.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
Proposed projects may address any topic related to the scientific study of prostate cancer, which include—but are not limited to—the prevention, diagnosis, treatment, or etiology of prostate cancer. Proposed research may be basic, translational, behavioral, or clinical in nature. Proposals are open to only faculty researchers.
Deadline: Tuesday, October 3, 2023
|
Moores Member Michael Bouvet, M.D. and the Local Committee of the ACS Institutional Research Grant (ACS-IRG-19-230-48-IRG) are pleased to announce the availability of seed money to stimulate cancer research projects among junior investigators at UC San Diego. Research proposals from all disciplines are encouraged and will be accepted. Proposals must demonstrate a clear relevance to cancer, and applicants reflecting a history of cancer-relevant research will be favored.
Deadline: Monday, October 9, 2023 at 5:00 p.m.
|
This mechanism provides support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute either Phase II or Phase II-linked Phase I (Phase I/II) kidney cancer clinical trials. These trials feature investigations of high-impact, novel therapeutic agents or approaches for the management or treatment of kidney cancer. Applicants must demonstrate a broad understanding of kidney cancer research, which includes knowledge of the current state of clinical studies and priorities related to kidney cancer. Applicants are encouraged to familiarize themselves with the FY23 Overarching Strategic Goals and Focus Areas to prepare an application. Support from this mechanism is to be directed toward consortium infrastructure needs rather than direct support of the trials themselves.
Deadline: Thursday, October 26, 2023
|
MRA) is pleased to announce an RFP for pre-clinical, translational, and early clinical research to produce high-impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment. Proposals must address a shortcoming in translational science (i.e., turning scientific discoveries into tools and/or treatments for high-risk individuals and patients with melanoma). Successful proposals will describe proposed research that applies important basic and preclinical discoveries to the near-term development of clinical trials and studies to improve melanoma detection, prevention, diagnosis, and/or treatment. Proposals for clinical studies to test well-defined and clearly articulated hypotheses are welcome and should be accompanied by a brief protocol synopsis and timeline that includes milestones. Eligibility and deadlines vary, depending on award type.
Deadline: Multiple—depending on award; see RFP for details.
|
|
|
Nature
John T. Chang, M.D. (Cancer Biology and Signaling), Sonia Sharma, M.D., Ph.D. (Cancer Biology and Signaling), and Ananda W. Goldrath, Ph.D. (Hematologic Malignancies)
|
Nature Immunology
Robert Saddawi-Konefka, M.D., Ph.D. (Cancer Biology and Signaling), Meghana Pagadala, Ph.D. (Structrual and Functional Genomics), Hannah Carter, Ph.D., M.Eng. (Structural and Functional Genomics), Jill P. Mesirov, Ph.D. (Structrual and Functional Genomics), and J. Silvio Gutkind, Ph.D. (Cancer Biology and Signaling)
|
Journal of Hepatology
Michael Karin, Ph.D. (Solid Tumor Therapeutics)
|
|
|
CLINICAL TRIALS OFFICE TRANSFORMATION INITIATIVE |
-
Over 100 CTO team members attended the all-staff town hall on August 30, 2023. CTO extremely values the feedback and participation. Although time did not allow leadership to address all questions, CTO took note of the questions and will incorporate them in future Town Halls and communications.
-
Based on feedback on current state processes and pain points, CTO has developed over 100 process improvement opportunities that target the improvement of efficiency and ways of working in the CTO.
-
Beyond implementing immediate process improvements, CTO also will identify additional investments to (1) remove barriers to trial participation for underserved patients in San Diego communities and (2) provide the necessary tools and technology for investigators and staff to efficiently develop, manage, and execute complex trials. Be on the lookout for updates.
-
Please keep your feedback coming. CTO needs your insight because it plays an essential role in the ongoing efforts to transform the CTO.
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
Community Health Equity Collaborative (CHEC) Meet and Greet Session
|
Last Thursday, September 7, 2023, COE hosted its second meet and greet session through the Community Health Equity Collaborative (CHEC) at the American Lung Association (ALA) offices. More than 20 CHEC members participated and received insight from the ALA regarding its ongoing lung cancer screening initiatives. Additionally, attendees had the opportunity to connect and network. COE sincerely appreciate all who were able to attend.
If you are interested in becoming part of the CHEC workgroup, then do not hesitate to contact COE at chec@health.ucsd.edu to join.
|
Community Health and Resource Fair at the Jackie Robinson Family YMCA
|
Last Wednesday, September 6, 2023, COE represented Moores at the monthly health fair held at the Jackie Robinson YMCA. Engaging with over 100 individuals, COE distributed educational materials and resources, with a special emphasis on recognizing September as Prostate and Ovarian Cancer Awareness Month.
If you are interested in participating in the next monthly health fair with COE on Wednesday, October 4, 2023, then please contact COE at mcccoe@health.ucsd.edu for more information.
|
Cervical Cancer Quality Improved Learning Collaborative
|
Thursday, September 21, 2023 | 12:00 p.m.
|
COE will host its third session for the Cervical Cancer Quality Improved Learning Collaborative on Thursday, September 21, 2023 at 12:00 p.m. The featured presentation on cross border collaborative efforts will be presented by Alicia Espinoza, M.P.H., Chief of Public Health Services Administration, Office of Border Health, County of San Diego, Health & Human Services Agency. Additional presentations will be announced soon. Eliminating the cervical cancer burden in our San Diego-Baja California border region will require all of us to work together.
If you are interested in learning more about this event, then please click the button below or contact COE at mcccoe@health.ucsd.edu. Thank you for helping to prevent cancer.
|
Community Market Health Fair
|
Sunday, September 24, 2023 | 10:00 a.m. to 2:00 p.m.
|
COE, along with Every Woman Counts, ACCESS, and the Asian Pacific Health Foundation, is excited to announce that it will be hosting a health fair on Sunday, September 24, 2023, from 10:00 a.m. to 2:00 p.m. This health fair will include not only various health screenings (e.g., blood pressure and cholesterol readings), but also cancer prevention education. This fair will be free and open to all who are interested. For more information, click the button below.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
3855 Health Sciences Drive MC 0698 | La Jolla, CA 92093 US
|
|
|
This email was sent to sjchristie@ucsd.edu.
To continue receiving our emails, add us to your address book.
|
|
|
|
